MedPath

Role of abdominal block for postoperative pain relief after total abdominal hysterectomy.

Not yet recruiting
Conditions
Postoperative pain
Registration Number
CTRI/2018/01/011163
Lead Sponsor
Tata Motors Hospital
Brief Summary

This study is a randomized, double blind, parallel group, evaluating efficacy of  Ultrasound guided Transversus Abdominis Plane (TAP) block in multimodal regimen after total abdominal hysterectomy patients done under combined spinal epidural aneasthesia technique in India. Subjects randomized in to two groups, Control group will receive standard postoperative analgesic treatment while study group will receive standard postoperative analgesic treatment and TAP block. The primary outcome measure will be assessment of duration of analgesia postoperatively within 24 hours. Secondary outcomes will be epidural morphine consumption, pain severity using visual analogue scores, Incidence of nausea-vomiting, pruritus, sedation and respiratory depression, complication of TAP block, Adverse effect of drug and patient satisfaction at 0, 2, 4, 6, 8, 10, 12, 18 and 24 hours.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
74
Inclusion Criteria
  • All patients undergoing total abdominal hysterectomy under combined spinal epidural anaesthesia after obtaining informed consent.
  • ASA grade I-III.
  • Total abdominal hysterectomy performed via lower abdominal transverse (Pfannenstiel) incision.
Exclusion Criteria
  • Patient refusal.
  • A history of drug allergy or local anaesthetic toxicity.
  • BMI >35kg/m2 (to limit maximum Ropivacaine dose to 3mg/kg) Contraindications to regional anaesthesia (bleeding diathesis, infection at the site of block and peripheral neuropathy) Change of anaesthetic technique to general anaesthesia.
  • Failure or complication in epidural catheter insertion.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of analgesia0,2,4,6,8,10,12,18 and 24 hr.
Secondary Outcome Measures
NameTimeMethod
Epidural morphine consumption.Severity of pain.

Trial Locations

Locations (1)

Tata Motors Hospital

🇮🇳

Singhbhum, JHARKHAND, India

Tata Motors Hospital
🇮🇳Singhbhum, JHARKHAND, India
Motaka Mayurkumar
Principal investigator
8092612434
mayur71039@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.